Literature DB >> 27832477

Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016.

Vineet Govinda Gupta1, Sameer Bakhshi2.   

Abstract

Hematopoietic stem cell transplantation (HSCT) refers to therapies that aim to eliminate a patient's hematopoietic and immune system and replace it with his own (autologous) or someone else's (allogenic) system. The applications of this therapy are vast and growing, and include several malignant and benign diseases incurable by any other existing modalities. Pediatric patients constitute a minority of HSCT recipients with unique concerns. Despite substantial progress in the last two decades, limitations due to financial, infrastructural, manpower and research constraints act as barriers to fulfilling the large need for pediatric HSCT services in our country. Limited availability of unrelated donors and cord blood units is another constraint. Here in this oration, we discuss the current issues pertaining to pediatric HSCT in India and describe our experience with the same.

Entities:  

Keywords:  AIIMS; Bone marrow transplantation; Cord blood transplantation; Stem cell transplantation; Unrelated donors

Mesh:

Year:  2016        PMID: 27832477     DOI: 10.1007/s12098-016-2253-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  40 in total

1.  Pediatric allogeneic stem cell transplantation: experience from the developing world.

Authors:  Satya Prakash Yadav; Anupam Sachdeva
Journal:  Pediatr Hematol Oncol       Date:  2013-04-24       Impact factor: 1.969

2.  Allogeneic bone marrow transplantation in the developing world: experience from a center in India.

Authors:  M Chandy; A Srivastava; D Dennison; V Mathews; B George
Journal:  Bone Marrow Transplant       Date:  2001-04       Impact factor: 5.483

3.  Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major.

Authors:  Sandip A Shah; Kamlesh M Shah; Kinnari A Patel; Asha S Anand; Shailesh S Talati; Harsha P Panchal; Apurva A Patel; Sonia K Parikh; Bhavesh B Parekh; Shilin N Shukla; Shreeniwas S Raut
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-19       Impact factor: 0.900

Review 4.  Stem cell transplantation in systemic sclerosis.

Authors:  Jacob M van Laar; Keith Sullivan
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

5.  Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.

Authors:  Galen E Switzer; Jessica G Bruce; Larissa Myaskovsky; Andrea DiMartini; Diana Shellmer; Dennis L Confer; Linda K Abress; Roberta J King; Allyson G Harnaha; Sibylle Ohngemach; Mary Amanda Dew
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

6.  Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India.

Authors:  R Kumar; R Naithani; P Mishra; M Mahapatra; T Seth; T K Dolai; R Bhargava; R Saxena
Journal:  Bone Marrow Transplant       Date:  2008-09-15       Impact factor: 5.483

Review 7.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist.

Authors:  Natasha Kekre; Joseph H Antin
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

8.  Infections among allogeneic bone marrow transplant recipients in India.

Authors:  B George; V Mathews; A Srivastava; M Chandy
Journal:  Bone Marrow Transplant       Date:  2004-02       Impact factor: 5.483

9.  Cost of hematopoietic stem cell transplantation in India.

Authors:  Sanjeev Kumar Sharma; Dharma Choudhary; Nitin Gupta; Mayank Dhamija; Vipin Khandelwal; Gaurav Kharya; Anil Handoo; Rasika Setia; Arpita Arora
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-01       Impact factor: 2.576

10.  Hematopoietic stem-cell transplantation in the developing world: experience from a center in Western India.

Authors:  Chirag A Shah; Arun Karanwal; Maharshi Desai; Munjal Pandya; Ravish Shah; Rutvij Shah
Journal:  J Oncol       Date:  2015-02-03       Impact factor: 4.375

View more
  1 in total

1.  Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy.

Authors:  Vineet Govinda Gupta; Ranga Rao Rangaraju; Waseem Abbas; Peush Bajpai; Ruchika Khetrapal
Journal:  South Asian J Cancer       Date:  2019 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.